Related Experiment Videos
Modulation of MDR/MRP by wild-type and mutant p53
The Journal of Clinical Investigation
|March 10, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Vitamin D decreases tumor cell growth and invasiveness in primary malignant bone tumors in vitro.
Journal of bone oncology·2026
Association of pre-radiotherapy tumour burden and overall survival in newly diagnosed glioblastoma adjusted for MGMT promoter methylation status.
European journal of cancer (Oxford, England : 1990)·2023
Investigating charge-up and fragmentation dynamics of oxygen molecules after interaction with strong X-ray free-electron laser pulses.
Physical chemistry chemical physics : PCCP·2022
Secondary post-tonsillectomy haemorrhage: is there evidence of diurnal and monthly variation in haemorrhage rates?
The Journal of laryngology and otology·2022
Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis.
Journal of neuro-oncology·2022
Tumor NLRP3 Amplification Promotes Immunotherapy Resistance by Inhibiting STAT1 Signaling and MHC Class I Expression.
The Journal of clinical investigation·2026
Insulin resistance is associated with mammary mitochondrial dysfunction at the onset of human lactation.
The Journal of clinical investigation·2026
Lactylation-dependent DDX18 nucleolar escape regulates CD44 mRNA stability to drive fibrotic progression in kidney injury.
The Journal of clinical investigation·2026
Metabolic stress-activated endothelial STING rewires the sinusoidal immune niche in MASLD.
The Journal of clinical investigation·2026
METTL1-mediated m7G modification of valine tRNAs drives metabolic adaptation in pancreatic ductal adenocarcinoma.
The Journal of clinical investigation·2026
Targeting the E3 ubiquitin ligase RNF10 ameliorates metabolic dysfunction-associated steatohepatitis in mice.
The Journal of clinical investigation·2026
Synergistic cell-cycle repression by HDAC/EZH2 co-targeting in H3K27-altered diffuse midline glioma.
Molecular therapy. Oncology·2026
In-depth characterization of stem cell potency and genotoxicity for clinical-scale ex vivo CRISPR-Cas9 gene editing.
Molecular therapy. Advances·2026
Baicalein targets the Nrf2/Keap1 interaction and related stress pathways to mitigate drug-induced toxicity and reverse resistance in breast cancer: A review.
International journal of biological macromolecules·2026
Exosomes as next-generation drug carriers: Transforming cancer therapy.
Journal of controlled release : official journal of the Controlled Release Society·2026